Cogstate logo
CGS

Cogstate

Health Care Equipment & Services

Cogstate Ltd is a neuroscience company focused on optimizing brain health assessments. They provide digital cognitive assessment tools and services for clinical trials, healthcare, and research, aiming to improve the detection and measurement of cognitive function. Their solutions support the development of new medicines and enable earlier clinical insights in healthcare.

Short position

short percentage0.03%
reported shorts46.8K
shares on issue171.989M

Cogstate (ASX:CGS) has 0.03% of its shares on issue reported as short positions as of 5 Oct 2026, or about 46,761 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.81% in July 2023. CGS is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Cogstate (CGS) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in USD, the reporting currency

Revenue
60.9M (source: ASX (Markit))vs 53.1M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Sep 2026
NPAT
11.9M (source: ASX (Markit))vs 10.1M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 29 Sep 2026
EPS (basic)
n/avs n/a (FY25)
Rev YoY
+14.6%FY
EPS YoY
n/aFY
  • ASX (Markit)

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 9 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
19.5%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a (reports in USD)
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (USD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 29 Sep 2026.

Financial statements

Figures in USD, the reporting currency; Yahoo Finance unless marked

CGS income, newest period first, figures in USD
Line itemFY26FY25FY24FY23
Revenue60.9M (source: ASX (Markit))53.1M (source: ASX (Markit))43.4M (source: ASX (Markit))40.5M (source: ASX (Markit))
NPAT11.9M (source: ASX (Markit))10.1M (source: ASX (Markit))5.4M (source: ASX (Markit))3.6M (source: ASX (Markit))
Shares169.9M168.9M170.8M173.2M
  • ASX (Markit)